Coronary Artery Bypass Graft (CABG) surgery is a medical procedure performed to improve blood flow to the heart muscle when the coronary arteries become narrowed or blocked. This condition, often caused by atherosclerosis, limits the supply of oxygen-rich blood to the heart, leading to chest pain (angina) or, in severe cases, heart attacks. During CABG, a surgeon grafts a healthy blood vessel, usually from the patient's leg or chest, to bypass the blocked or narrowed section of the coronary artery, creating a new pathway for blood to reach the heart muscle. This reestablishes proper blood flow and can alleviate symptoms, enhance heart function, and reduce the risk of future cardiac events. CABG is a well-established and effective intervention, often recommended when other treatments, such as medications or lifestyle changes, prove insufficient. Despite advancements in less invasive procedures, CABG remains a crucial option for individuals with complex coronary artery disease, contributing significantly to their cardiovascular health and overall well-being.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India